Partners GSK and Neopharma have produced the first batch of medicines at local Secondary Packaging stage
Press Release - 08-Jan-2020This first batch includes 35,000 packages of medicine
TradeArabia - 08-Jan-2020Neopharma a global pharmaceutical company will undertake commercializing responsibility through its presence in various countries of MENA & India
Press Release - 31-Oct-2019Neopharma a global pharmaceutical company will undertake commercializing responsibility through its presence in various countries of MENA & India.
Press Release - 29-Oct-2019The region's only event dedicated to pharma manufacturing returned to Abu Dhabi, welcoming over 3,100 visitors from 98 countries
Press Release - 16-Oct-2019Via the partnership, SDO and ADVOC will operate in the region as a single sales and marketing team
Press Release - 19-Aug-2019GSK partners with Neopharma to localize its Secondary Packaging stage - the last phase of the manufacturing process before distribution and sale.
Press Release - 29-Apr-2019The Bristol site has had a long history first with the British drug maker GlaxoSmithKline (GSK) and then with Dr. Reddy's in manufacturing the brands Augmentin® and Amoxil®.
Press Release - 07-Oct-2018Neopharma has five globally accredited pharmaceutical manufacturing facilities in three continents
Khaleej Times - 06-Oct-2018Takeover conducted on Monday for an undisclosed sum
Mubasher - 02-Oct-2018H.E. Dr.
Press Release - 22-Oct-2017The factory in Japan will manufacture supplements for patients in pre-diabetic stage and also Type II diabetic patients.
Press Release - 21-May-2017NeoBiocon, a collaboration between Asia's leading biopharmaceuticals company Biocon Ltd and Dr. B.R. Shetty, Chairman of the UAE-based Neopharma, announced today that it has partnered with Novartis Middle East FZE, to market Jalra (Vildagliptin) and Jalra-M (Vildagliptin + Metformin) in UAE. This partnership will help NeoBiocon expand its product offerings in the
Press Release - 09-Dec-2015